• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫亲和捕获结合质谱法鉴定 HLA 结合肽。

Isolation of HLA Bound Peptides by Immunoaffinity Capture and Identification by Mass Spectrometry.

机构信息

Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.

出版信息

Curr Protoc. 2021 Mar;1(3):e92. doi: 10.1002/cpz1.92.

DOI:10.1002/cpz1.92
PMID:33769717
Abstract

This article describes the purification of HLA-bound peptides and their subsequent sequencing by mass spectrometry. These methods can be used for both HLA class I and class II molecules and can be adapted to different species depending on the availability of specific antibodies. Peptides can be successfully isolated from a variety of sample types, including in vitro cultured cells and primary tissues. The method involves the affinity capture of HLA-peptide complexes and separation of peptides from HLA heavy chains, followed by tailored interrogation by mass spectrometry to take into account the non-tryptic nature of endogenously derived HLA-bound peptides. © 2021 Wiley Periodicals LLC. Basic Protocol 1: Preparation of immunoaffinity column Alternate Protocol 1: Preparation of microscale immunoaffinity column Basic Protocol 2: Generation of cell lysate and HLA immunoaffinity purification Alternate Protocol 2: Microscale immunoaffinity purification Basic Protocol 3: Separation of HLA peptides by reverse-phase high-performance liquid chromatography (RP-HPLC) Alternate Protocol 3: Isolation of HLA peptides using molecular weight cutoff (MWCO) filter Basic Protocol 4: Mass spectrometry and data analysis.

摘要

本文描述了 HLA 结合肽的纯化及其随后通过质谱进行测序。这些方法可用于 HLA Ⅰ类和Ⅱ类分子,并且可以根据特定抗体的可用性适应不同的物种。肽可以成功地从各种类型的样品中分离出来,包括体外培养的细胞和原代组织。该方法涉及 HLA-肽复合物的亲和捕获以及肽与 HLA 重链的分离,然后通过质谱进行定制化分析,以考虑内源性 HLA 结合肽的非胰蛋白酶性质。© 2021 Wiley Periodicals LLC. 基本方案 1:免疫亲和柱的制备 可选方案 1:微尺度免疫亲和柱的制备 基本方案 2:细胞裂解物的产生和 HLA 免疫亲和纯化 可选方案 2:微尺度免疫亲和纯化 基本方案 3:反相高效液相色谱 (RP-HPLC) 分离 HLA 肽 可选方案 3:使用分子量截止 (MWCO) 过滤器分离 HLA 肽 基本方案 4:质谱和数据分析。

相似文献

1
Isolation of HLA Bound Peptides by Immunoaffinity Capture and Identification by Mass Spectrometry.免疫亲和捕获结合质谱法鉴定 HLA 结合肽。
Curr Protoc. 2021 Mar;1(3):e92. doi: 10.1002/cpz1.92.
2
Mass spectrometry-based identification of MHC-bound peptides for immunopeptidomics.基于质谱的 MHC 结合肽鉴定用于免疫肽组学。
Nat Protoc. 2019 Jun;14(6):1687-1707. doi: 10.1038/s41596-019-0133-y. Epub 2019 May 15.
3
High-Throughput, Fast, and Sensitive Immunopeptidomics Sample Processing for Mass Spectrometry.用于质谱分析的高通量、快速且灵敏的免疫肽组学样本处理方法
Methods Mol Biol. 2019;1913:67-79. doi: 10.1007/978-1-4939-8979-9_5.
4
A microcapillary column switching HPLC-electrospray ionization MS system for the direct identification of peptides presented by major histocompatibility complex class I molecules.一种用于直接鉴定由主要组织相容性复合体I类分子呈递的肽段的微毛细管柱切换高效液相色谱-电喷雾电离质谱系统。
Anal Chem. 1998 Sep 15;70(18):3742-51. doi: 10.1021/ac9801014.
5
Analysis of naturally processed peptides eluted from HLA DRB1*0402 and *0404.从HLA DRB1*0402和*0404洗脱的天然加工肽段分析。
J Neurosci Res. 1996 Sep 15;45(6):795-802. doi: 10.1002/(SICI)1097-4547(19960915)45:6<795::AID-JNR16>3.0.CO;2-V.
6
Purification and Identification of Naturally Presented MHC Class I and II Ligands.天然呈递的MHC I类和II类配体的纯化与鉴定
Methods Mol Biol. 2019;1988:123-136. doi: 10.1007/978-1-4939-9450-2_10.
7
Separation of complexes of major histocompatibility class II molecules and known antigenic peptide by metal chelate affinity chromatography.通过金属螯合亲和色谱法分离主要组织相容性复合体II类分子与已知抗原肽的复合物。
J Immunol Methods. 1994 Mar 10;169(2):273-85. doi: 10.1016/0022-1759(94)90271-2.
8
HPLC and MS analysis for the identification and characterisation of peptides presented in the context of the non-classical human leukocytes antigen (HLA) class I molecule HLA-E.高效液相色谱法和质谱分析鉴定和特征肽呈现在非经典人类白细胞抗原(HLA)类 I 分子 HLA-E 方面。
Curr Pharm Des. 2009;15(28):3325-35. doi: 10.2174/138161209789105126.
9
Selective isolation and identification of HLA-DR-associated naturally processed and presented epitope peptides.HLA-DR相关自然加工和呈递表位肽的选择性分离与鉴定。
Immunol Invest. 2003 Aug;32(3):155-69. doi: 10.1081/imm-120022976.
10
Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome.轻度酸洗脱和 MHC 免疫亲和色谱法揭示了 HLA I 类免疫肽组相似但不完全相同的特征。
J Proteome Res. 2021 Jan 1;20(1):289-304. doi: 10.1021/acs.jproteome.0c00386. Epub 2020 Nov 3.

引用本文的文献

1
Tumor-derived exosomes and their application in cancer treatment.肿瘤衍生的外泌体及其在癌症治疗中的应用。
J Transl Med. 2025 Jul 8;23(1):751. doi: 10.1186/s12967-025-06814-7.
2
Endogenous viral elements constitute a complementary source of antigens for personalized cancer vaccines.内源性病毒元件构成了个性化癌症疫苗抗原的补充来源。
NPJ Vaccines. 2025 Mar 20;10(1):54. doi: 10.1038/s41541-025-01107-y.
3
Multiple Classes of Antigen Contribute to the Antigenic Landscape of Mesothelioma.多种抗原类别促成了间皮瘤的抗原格局。
Mol Cell Proteomics. 2025 Mar;24(3):100925. doi: 10.1016/j.mcpro.2025.100925. Epub 2025 Feb 5.
4
Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma.联合 ERAP1 沉默和恩替诺特治疗克服神经母细胞瘤对癌症免疫治疗的耐药性。
J Exp Clin Cancer Res. 2024 Oct 22;43(1):292. doi: 10.1186/s13046-024-03180-y.
5
Mapping the immunopeptidome of seven SARS-CoV-2 antigens across common HLA haplotypes.绘制七种 SARS-CoV-2 抗原在常见 HLA 单倍型上的免疫肽组图谱。
Nat Commun. 2024 Aug 30;15(1):7547. doi: 10.1038/s41467-024-51959-6.
6
A Simple and Rapid Protocol for the Isolation of Murine Bone Marrow Suitable for the Differentiation of Dendritic Cells.一种简单快速的用于分离适合树突状细胞分化的小鼠骨髓的方法。
Methods Protoc. 2024 Feb 27;7(2):20. doi: 10.3390/mps7020020.
7
DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma.DNAJB1-PRKACA 融合新抗原引发罕见的内源性 T 细胞反应,增强了纤维板层肝细胞癌的细胞治疗效果。
Cell Rep Med. 2024 Mar 19;5(3):101469. doi: 10.1016/j.xcrm.2024.101469.
8
Development of a semi-automated MHC-associated peptide proteomics (MAPPs) method using streptavidin bead-based immunoaffinity capture and nano LC-MS/MS to support immunogenicity risk assessment in drug development.开发一种基于链霉亲和素珠的免疫亲和捕获和纳升液相色谱-串联质谱的半自动化 MHC 相关肽蛋白质组学 (MAPPs) 方法,以支持药物开发中的免疫原性风险评估。
Front Immunol. 2023 Nov 10;14:1295285. doi: 10.3389/fimmu.2023.1295285. eCollection 2023.
9
Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma.局限于HLA-A∗02:01的内源性H3.3K27M衍生肽不足以在弥漫性中线胶质瘤中进行免疫靶向。
Mol Ther Oncolytics. 2023 Aug 15;30:167-180. doi: 10.1016/j.omto.2023.08.005. eCollection 2023 Sep 21.
10
A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma.一种结合免疫肽组学、蛋白质组学和细胞表面蛋白质组学的方法来鉴定弥漫性脑桥胶质瘤的免疫治疗靶点。
Front Oncol. 2023 Aug 11;13:1192448. doi: 10.3389/fonc.2023.1192448. eCollection 2023.